Current Studies

This page includes information on studies we are currently recruiting for.

For more information about any of our studies:

Elizabeth

773-702-9066

ec642@bsd.uchicago.edu

Stephanie

773-834-3778

valles@uchicago.edu

 

Trichotillomania 

“Silymarin Treatment of Trichotillomania in Children and Adults: A Double-Blind, Placebo-Controlled, Cross-Over Study”

A 13 week research study using an experimental supplement for hair pulling. For ages 10-65.

“Body Focused Repetitive Behavior Precision Medicine Initiative”
A research study to better understand Hair Pulling Disorder and Skin Picking Disorder.

Skin Picking

“Body Focused Repetitive Behavior Precision Medicine Initiative”
A research study to better understand Hair Pulling Disorder and Skin Picking Disorder.

OCD

“Tolcapone Treatment of Obsessive Compulsive Disorder: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study”

“A randomized, double-blind, placebo-controlled trial of adjunctive BHV-4157 in Obsessive Compulsive Disorder”
A 12 week experimental drug study for people with OCD who have had an inadequate response to prior therapy.
Complete form at: https://www.surveymonkey.com/r/OCDRecruitment or

“Tolcapone in Impulsivity and Compulsivity”
A 2 visit MRI study for people with OCD testing the effects of the medication Tolcapone on the brain.

Impulse Control Disorders

“Susceptibility to Pathological Gambling” (Non-treatment, not currently recruiting)
A research study to to better understand of measures that may be taken to prevent people from becoming pathological gamblers.
Complete the form at: https://www.surveymonkey.com/s/ACIDGambling

“Silymarin Treatment of Pathological Gambling: A Double-Blind, Placebo-Controlled Study”
An 8 week experimental study using a natural supplement for gambling.

“Role of Dopamine in Impulsivity and Compulsivity”
A 2 visit MRI study for people with OCD, impusivity, and healthy controls.

Neurodevelopmental Disorders

“Balovaptan in Autism”

A research study to to better evaluate the efficacy, safety, and tolerability of Blovaptan compared to placebo for reducing the symptoms of Autism Spectrum Disorder ASD). 

Personality Disorders

“Brexpiprazole in Borderline Personality Disorder”
A research study to to evaluate the safety and efficacy of Brexpiprazole in adults with borderline personality disorder (BPD).

Skip to toolbar